![Understanding of molecular mechanisms in natural killer cell therapy | Experimental & Molecular Medicine Understanding of molecular mechanisms in natural killer cell therapy | Experimental & Molecular Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Femm.2014.114/MediaObjects/12276_2015_Article_BFemm2014114_Fig1_HTML.jpg)
Understanding of molecular mechanisms in natural killer cell therapy | Experimental & Molecular Medicine
![The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy: Molecular Therapy - Oncolytics The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy: Molecular Therapy - Oncolytics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2128ac3b-09ef-4bbe-870a-b5daff0345c2/fx1.jpg)
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy: Molecular Therapy - Oncolytics
![Developmental pathways that generate natural-killer-cell diversity in mice and humans | Nature Reviews Immunology Developmental pathways that generate natural-killer-cell diversity in mice and humans | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnri2154/MediaObjects/41577_2007_Article_BFnri2154_Fig1_HTML.jpg)
Developmental pathways that generate natural-killer-cell diversity in mice and humans | Nature Reviews Immunology
![Mechanisms of natural killer cell‐mediated cellular cytotoxicity - Prager - 2019 - Journal of Leukocyte Biology - Wiley Online Library Mechanisms of natural killer cell‐mediated cellular cytotoxicity - Prager - 2019 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/cfad13c9-1963-4cbf-aa51-eb531f5c8a7e/jlb10399-gra-0001-m.jpg)
Mechanisms of natural killer cell‐mediated cellular cytotoxicity - Prager - 2019 - Journal of Leukocyte Biology - Wiley Online Library
![Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations - Journal of Allergy and Clinical Immunology Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5a910685-32b5-4a9d-b051-f68271969473/fx1_lrg.jpg)
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations - Journal of Allergy and Clinical Immunology
![Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells | Scientific Reports Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-51287-6/MediaObjects/41598_2019_51287_Fig1_HTML.png)
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells | Scientific Reports
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study | Haematologica
![Frontiers | Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities | Immunology Frontiers | Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/436512/436512_Thumb_400.jpg)
Frontiers | Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities | Immunology
![Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways: Molecular Therapy - Methods & Clinical Development Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways: Molecular Therapy - Methods & Clinical Development](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/899b7faa-aee0-4fff-843e-de6a20e88175/fx1_lrg.jpg)
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways: Molecular Therapy - Methods & Clinical Development
![Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function - ScienceDirect Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721005593-fx1.jpg)
Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function - ScienceDirect
![Cancers | Free Full-Text | Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy | HTML Cancers | Free Full-Text | Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy | HTML](https://www.mdpi.com/cancers/cancers-11-00769/article_deploy/html/images/cancers-11-00769-g001.png)
Cancers | Free Full-Text | Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy | HTML
![High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice - Gastroenterology High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1fe7bc38-e956-4175-a088-84b111b8e2dc/fx1_lrg.jpg)
High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice - Gastroenterology
![Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy | Journal of Hematology & Oncology | Full Text Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01083-5/MediaObjects/13045_2021_1083_Fig1_HTML.png)
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy | Journal of Hematology & Oncology | Full Text
![Frontiers | Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors | Oncology Frontiers | Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/436956/436956_Thumb_400.jpg)
Frontiers | Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors | Oncology
![Interleukin-18 up-regulates amino acid transporters and facilitates amino acid–induced mTORC1 activation in natural killer cells - Journal of Biological Chemistry Interleukin-18 up-regulates amino acid transporters and facilitates amino acid–induced mTORC1 activation in natural killer cells - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/3151b19b-a310-4d61-a329-0fe6a55eeec7/gr1.jpg)
Interleukin-18 up-regulates amino acid transporters and facilitates amino acid–induced mTORC1 activation in natural killer cells - Journal of Biological Chemistry
![Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future | Stem Cell Research & Therapy | Full Text Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13287-021-02277-x/MediaObjects/13287_2021_2277_Fig1_HTML.png)
Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future | Stem Cell Research & Therapy | Full Text
![Frontiers | Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy? | Immunology Frontiers | Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy? | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/491312/491312_Thumb_400.jpg)
Frontiers | Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy? | Immunology
![Generation and validation of CRISPR-engineered human natural killer cell lines for research and therapeutic applications: STAR Protocols Generation and validation of CRISPR-engineered human natural killer cell lines for research and therapeutic applications: STAR Protocols](https://hivebench-star-protocols.s3.amazonaws.com/protocols/1115-GA.jpg)